JP2023504826A5 - - Google Patents

Info

Publication number
JP2023504826A5
JP2023504826A5 JP2022533406A JP2022533406A JP2023504826A5 JP 2023504826 A5 JP2023504826 A5 JP 2023504826A5 JP 2022533406 A JP2022533406 A JP 2022533406A JP 2022533406 A JP2022533406 A JP 2022533406A JP 2023504826 A5 JP2023504826 A5 JP 2023504826A5
Authority
JP
Japan
Prior art keywords
recombinase
sequence
seq
fusion protein
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022533406A
Other languages
English (en)
Japanese (ja)
Other versions
JP7702149B2 (ja
JP2023504826A (ja
Filing date
Publication date
Priority claimed from EP19214152.1A external-priority patent/EP3831939A1/en
Application filed filed Critical
Publication of JP2023504826A publication Critical patent/JP2023504826A/ja
Publication of JP2023504826A5 publication Critical patent/JP2023504826A5/ja
Application granted granted Critical
Publication of JP7702149B2 publication Critical patent/JP7702149B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022533406A 2019-12-06 2020-12-03 効率的かつ特異的なゲノム編集のための部位特異的リコンビナーゼの融合 Active JP7702149B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19214152.1 2019-12-06
EP19214152.1A EP3831939A1 (en) 2019-12-06 2019-12-06 Fusion of site-specific recombinases for efficient and specific genome editing
PCT/EP2020/084489 WO2021110846A1 (en) 2019-12-06 2020-12-03 Fusion of site-specific recombinases for efficient and specific genome editing

Publications (3)

Publication Number Publication Date
JP2023504826A JP2023504826A (ja) 2023-02-07
JP2023504826A5 true JP2023504826A5 (cg-RX-API-DMAC7.html) 2023-07-14
JP7702149B2 JP7702149B2 (ja) 2025-07-03

Family

ID=68808195

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022533406A Active JP7702149B2 (ja) 2019-12-06 2020-12-03 効率的かつ特異的なゲノム編集のための部位特異的リコンビナーゼの融合

Country Status (8)

Country Link
US (1) US20250243473A1 (cg-RX-API-DMAC7.html)
EP (2) EP3831939A1 (cg-RX-API-DMAC7.html)
JP (1) JP7702149B2 (cg-RX-API-DMAC7.html)
CN (1) CN115427558A (cg-RX-API-DMAC7.html)
AU (1) AU2020396214B2 (cg-RX-API-DMAC7.html)
CA (1) CA3163359A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022006799A (cg-RX-API-DMAC7.html)
WO (1) WO2021110846A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3638776T3 (pl) 2017-06-14 2026-02-23 Technische Universität Dresden Sposoby i środki do zmiany genetycznej genomów z wykorzystaniem projektowanych enzymów rekombinujących dna
CA3232485A1 (en) * 2021-11-15 2023-05-19 Technische Universitat Dresden Site-specific recombinases for efficient and specific genome editing
AU2024363742A1 (en) * 2023-10-16 2026-04-30 Technische Universität Dresden Körperschaft Des Öffentlichen Rechts Conditioned dna modifying enzyme comprising heterologous dna binding domain
US20260049306A1 (en) 2024-07-25 2026-02-19 Technische Universität Dresden Körperschaft Des Öffentlichen Rechts Modifying nucleic acid sequences having asymmetric target sites

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981830A (en) 1997-05-30 1999-11-09 Schering Aktiengesellschaft Knockout mice and their progeny with a disrupted hepsin gene
AU745960C (en) * 1997-11-18 2003-09-18 Pioneer Hi-Bred International, Inc. A novel method for the integration of foreign DNA into eukaryoticgenomes
GB0029375D0 (en) * 2000-12-01 2001-01-17 Total Fina Elf Substrate linked directed evolution (slide)
US20060014264A1 (en) * 2004-07-13 2006-01-19 Stowers Institute For Medical Research Cre/lox system with lox sites having an extended spacer region
EP1942192A1 (en) 2007-01-08 2008-07-09 Heinrich-Pette-Institut für experimentelle Virologie und Immunologie Use of a tailored recombinase for the treatment of retroviral infections
CN103154256A (zh) 2010-05-27 2013-06-12 海因里希·佩特研究所莱比锡试验病毒学研究所-民法基金会 用于使多种逆转录病毒毒株中的不对称靶位点重组的修整重组酶
CN105531375B (zh) * 2012-12-10 2020-03-03 分析生物科学有限公司 靶向基因组分析的方法
EP2993229A1 (en) 2014-09-02 2016-03-09 Heinrich-Pette-Institut Leibniz-Institut für experimentelle Virologie-Stiftung bürgerlichen Rechts - Well-tolerated and highly specific tailored recombinase for recombining asymmetric target sites in a plurality of retrovirus strains
US10017832B2 (en) * 2015-08-25 2018-07-10 Washington University Compositions and methods for site specific recombination at asymmetric sites
PL3638776T3 (pl) 2017-06-14 2026-02-23 Technische Universität Dresden Sposoby i środki do zmiany genetycznej genomów z wykorzystaniem projektowanych enzymów rekombinujących dna
IL278546B2 (en) * 2018-05-09 2026-03-01 Keros Therapeutics Inc Activin receptor type IIA variants and methods of using them

Similar Documents

Publication Publication Date Title
US12203077B2 (en) Fusion proteins for improved precision in base editing
AU2018240571B2 (en) Nucleobase editors comprising nucleic acid programmable DNA binding proteins
CN107109422B (zh) 使用由两个载体表达的拆分的Cas9的基因组编辑
US20240401018A1 (en) Evolved double-stranded dna deaminase base editors and methods of use
WO2021178717A2 (en) Improved methods and compositions for modulating a genome
JP2022516130A5 (cg-RX-API-DMAC7.html)
SG11202108303SA (en) Inhibition of unintended mutations in gene editing
JP2021522783A5 (cg-RX-API-DMAC7.html)
JP2025510586A5 (cg-RX-API-DMAC7.html)
JP2022529329A (ja) 人工的に構築されたrna編集酵素による部位特異的rna編集および関連使用
KR20180069898A (ko) 핵염기 편집제 및 그의 용도
EP4337701A1 (en) Effector proteins and methods of use
CA3225808A1 (en) Context-specific adenine base editors and uses thereof
CN114144519B (zh) 单碱基置换蛋白以及包含其的组合物
US20250312376A1 (en) Compositions and methods for modulating a genome in t cells, induced pluripotent stem cells, and respiratory epithelial cells
WO2023250148A1 (en) Compositions and methods for epigenetic editing
JP2024531607A5 (cg-RX-API-DMAC7.html)
KR102151064B1 (ko) 매칭된 5' 뉴클레오타이드를 포함하는 가이드 rna를 포함하는 유전자 교정용 조성물 및 이를 이용한 유전자 교정 방법
KR102937433B1 (ko) 표적 특이적 crispr 변이체
CN120098961A (zh) 一种具有高活性和高保真性的saCas9蛋白变体及其应用
CN118649229A (zh) 工程化Cas9蛋白及其制备方法和应用
JP2026507559A (ja) Crisprトランスポゾンシステム及び構成要素
CN113652411A (zh) Cas9蛋白、含有Cas9蛋白的基因编辑系统及应用
US20160138047A1 (en) Improved polynucleotide sequences encoding tale repeats
WO2023207607A1 (zh) 用于修饰线粒体dna的脱氨酶突变体、组合物和方法